Dianthus Therapeutics Inc (DNTH)

02:47 AM

What drives Dianthus Therapeutics Inc 87E stock priceLow Risk Investment Ideas & Low Cost Trading Tips - earlytimes.in

02:47 AM

Dec 06, 2025

Dianthus Therapeutics (NASDAQ:DNTH) CFO Ryan Savitz Sells 20,000 Shares - MarketBeat

Dec 06, 2025

Dec 05, 2025

Dianthus Therapeutics CFO & CBO Ryan Savitz Sells 20,000 Shares - TradingView

Dec 05, 2025

Dec 05, 2025

CFO Savitz Sells 20,000 ($903.6K) Of Dianthus Therapeutics Inc [DNTH] - TradingView

Dec 05, 2025

Dec 05, 2025

Ashland, Bitdeer, and More Stocks See Action From Activist Investors - Barron's

Dec 05, 2025

Dec 05, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week HighHere's Why - MarketBeat

Dec 05, 2025

Dec 05, 2025

Nothing is Better Than Dianthus Therapeutics Inc (DNTH) stock at the moment - Setenews

Dec 05, 2025

Dec 05, 2025

27,003 Shares in Dianthus Therapeutics, Inc. $DNTH Bought by XTX Topco Ltd - MarketBeat

Dec 05, 2025

Dec 05, 2025

Geode Capital Management LLC Has $9.04 Million Stock Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Dec 05, 2025

Dec 05, 2025

Can Dianthus Therapeutics Inc. (87E) stock sustain breakout momentum2025 AllTime Highs & Detailed Earnings Play Alerts - Newser

Dec 05, 2025

Dec 04, 2025

CFO Savitz Files To Sell 20,000 Of Dianthus Therapeutics Inc [DNTH] - TradingView

Dec 04, 2025

Dec 04, 2025

Is Dianthus Therapeutics Inc. (87E) stock a contrarian opportunityWeekly Loss Report & Real-Time Volume Analysis - Newser

Dec 04, 2025

Dec 04, 2025

Dianthus Therapeutics stock hits 52-week high at 45.0 USD - Investing.com

Dec 04, 2025

Dec 04, 2025

Can Dianthus Therapeutics Inc. (87E) stock deliver double digit returnsPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser

Dec 04, 2025

Dec 04, 2025

Will Dianthus Therapeutics Inc. (87E) stock outperform value peersTrade Risk Assessment & Low Risk High Reward Ideas - Newser

Dec 04, 2025

Dec 03, 2025

Dianthus Therapeutics, Inc. $DNTH Shares Bought by Sio Capital Management LLC - MarketBeat

Dec 03, 2025

Dec 02, 2025

CapEx per share of Dianthus Therapeutics, Inc. – TRADEGATE:87E - TradingView

Dec 02, 2025

Dec 02, 2025

Dianthus Therapeutics (DNTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 02, 2025

DNTH: Advancing two autoimmune therapies with strong clinical data and $525M cash runway - TradingView

Dec 02, 2025

Nov 28, 2025

Ensign Peak Advisors Inc Invests $2.50 Million in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Nov 28, 2025

Nov 26, 2025

Stocks of Dianthus Therapeutics Inc (DNTH) are poised to climb above their peers - Setenews

Nov 26, 2025

Nov 26, 2025

Fed fueled market rally dnth breakout setup and ethereums critical test zone ahead | Fundamental analysis - RichTv

Nov 26, 2025

Nov 25, 2025

Avidity Partners Management LP Reduces Stake in Dianthus Therape - GuruFocus

Nov 25, 2025

Nov 25, 2025

What analysts say about Dianthus Therapeutics Inc stockStock Buy Signals & Top Analyst Picks Available for Free - earlytimes.in

Nov 25, 2025

Nov 24, 2025

Dianthus Therapeutics stock hits 52-week high at 43.69 USD By Investing.com - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times

Nov 24, 2025

Nov 24, 2025

Dianthus Therapeutics (Nasdaq: DNTH) joins 8th Evercore Healthcare Conference on Dec. 2 - Stock Titan

Nov 24, 2025

Nov 23, 2025

The Insider Report: Prepare for the Next Dip Buying Opportunity - Benzinga

Nov 23, 2025

Nov 22, 2025

DNTH SEC FilingsDianthus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Nov 22, 2025

Nov 21, 2025

Wedbush Maintains Dianthus Therapeutics (DNTH) Outperform Recommendation - MSN

Nov 21, 2025

Nov 19, 2025

How forex fluctuations impact Dianthus Therapeutics Inc. (87E) stockPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Why Dianthus Therapeutics Inc. stock remains resilient2025 Short Interest & Real-Time Volume Triggers - newser.com

Nov 19, 2025

Nov 19, 2025

How Dianthus Therapeutics Inc. (87E) stock performs in easing cyclesCEO Change & Daily Entry Point Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Dianthus Therapeutics Inc. stock reacts to global recession fearsJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Views of Wall Street’s Leading Experts on Dianthus Therapeutics Inc - Setenews

Nov 19, 2025

Nov 19, 2025

Dianthus Therapeutics (DNTH): Reviewing Valuation Following Widening Losses in Latest Earnings Results - Sahm

Nov 19, 2025

Nov 18, 2025

Smart tools for monitoring Dianthus Therapeutics Inc.’s price action2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

What analysts say about Dianthus Therapeutics Inc 87E stock - earlytimes.in

Nov 18, 2025

Nov 18, 2025

How to escape a deep drawdown in Dianthus Therapeutics Inc.Earnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com

Nov 18, 2025

Nov 17, 2025

Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $3,221,132.67 in Stock - Defense World

Nov 17, 2025

Nov 17, 2025

Candriam S.C.A. Has $4.48 Million Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Nov 17, 2025

Nov 17, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 17, 2025

Nov 17, 2025

Dianthus Therapeutics Insider Sold Shares Worth $7,379,887, According to a Recent SEC Filing - MarketScreener

Nov 17, 2025

Nov 17, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Hits New 12-Month High – Here’s Why - Defense World

Nov 17, 2025

Nov 16, 2025

Dianthus Therapeutics (NASDAQ:DNTH) EVP Simrat Randhawa Sells 109,031 Shares - MarketBeat

Nov 16, 2025